摘要
目的:观察劳氏颈椎Ⅰ号方治疗神经根型颈椎病的临床疗效,为新药开发作理论基础。方法:将100例神经根型颈椎病患者随机分为治疗组60例(采用劳氏颈椎Ⅰ号方治疗)和对照组40例(采用颈复康颗粒治疗),两组均配合颈椎牵引治疗,4周后观察两组患者主要症状、体征的变化,并评价劳氏颈椎Ⅰ号方的疗效及安全性。结果:在主要症状、体征的改善和临床疗效方面,治疗组优于对照组,差异具有统计学意义(P<0.05),治疗组未见有明显的不良反应。结论:劳氏颈椎Ⅰ号方治疗神经根型颈椎病效果良好,未发现明显的不良反应。
Objective： To observe the curative effect of LAOSHIJINGZHUI Ⅰ Prescription on treatment of cervical spondylotic radiculopathy and provide theoretical foundation for developing new drugs. Methods： 100 patients were randomly divided into 2 groups. 60 patients in therapeutic group were administered with LAOSHIJINGZHUI Ⅰ Prescription, while 40 patients in control group were administered with JINGFUKANG granules. In the same time, all patients were treated with cervical traction. 4 weeks later, the variations in the main symptoms and physical sign of these patients were observed and the curative effect and safety of LAOSHIJINGZHUI I Prescription were evaluated. Results： The curative effect in therapeutic group was better than that in control group and there was statistical difference between the two groups （ P 〈 0.05 ）. The situation is same in the variations in the main symptoms and physical sign of these patients. Less adverse reaction occurred in therapeutic group. Conclusion ： LAOSHIJINGZHUI Ⅰ Prescription has significant curative effect on cervical spondylotic radiculopathy and less adverse reaction were found.
出处
《中医正骨》
2009年第4期4-6,共3页
The Journal of Traditional Chinese Orthopedics and Traumatology
基金
浙江省卫生厅中医药科技计划项目(编号2007CB202)
关键词
颈椎病
神经根病
中药疗法
劳氏颈椎1号方
Cervical spoodylosis, Radiculopathy, Drug therapy（ TCD）, LAOSHIJINGZHUI Ⅰ Prescription
